Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 38.000 / 126.278K |
Day Range | - - - |
52 Wk Range | 8.250 - 27.900 |
Market Cap | $70.753M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 4.51% |
Days to Cover | 2.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Kezar Life Sciences (NASDAQ:KZR), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Eagle Pharmaceuticals (NASDAQ:EGRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by HC Wainwright & Co. on Wednesday, April 17, 2024. The analyst firm set a price target for 60.00 expecting DTIL to rise to within 12 months (a possible 486.51% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $10.23 last updated April 24, 2024 at 9:27 AM EDT.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.